The document discusses Google Ventures' investment strategy, particularly in life sciences, led by Bill Maris. It highlights the firm's investment in Foundation Medicine, a company using genetic data for oncology tools, which has gained significant attention after Roche Holding's investment. The document also touches on the challenges of investing in biotech companies and the need for scientific expertise.
documents/vol00010-efta01457176-pdf.pdf
{"key_people":["Bill Maris","David Krane","Joe Kraus","Rich Miner","Tristan Prettyman","Dr. Michael Pellini","Eric Lander"],"document_type":"correspondence","key_locations":["Silicon Valley","San Francisco"],"key_organizations":["Google Ventures","Foundation Medicine","Roche Holding","JPMorgan Chase","Human Genome Project"]}